Attenuation of Corticosteroid Induced Hippocampal Changes

Completed · Phase 4 · Has a placebo group

Conditions studied: Organic Memory Impairment

In brief

The purpose of the study is to determine if an investigational drug called memantine,used here as add-on therapy, is associated with improvements in memory, mood and asthma symptoms. We will also examine changes in the brain by taking images or pictures using an MRI/MRS.

Key facts

Study ID
NCT01656187
Run by
University of Texas Southwestern Medical Center
People needed
46
Starts
2012-01-01
Expected to finish
2017-01-01
Last updated by the study team
2019-03-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.